Man With Super Medical Skill by Matthew

Chapter 426

Alas, Theodore and the rest agreed to Matthew's terms. After they signed a contract of 50 million each, they left.

Not long after their departure, more people came to meet Sasha. This time around, it was Daniel and the others. Previously, they had approached Cunningham Pharmaceuticals to sign a three-billion-dollar order. However, they cut ties with Cunningham Pharmaceuticals after the incident with the Hughes occurred.

At the time, what they did dealt a huge blow to Cunningham Pharmaceuticals-the company nearly went bankrupt because Daniel and the others had breached their contracts. To be honest, with their strength and status, they did not need to fear the Hughes. However, the Hughes had promised them some benefits.

Moreover, they were certain that the Hughes would be able to bring down Cunningham Pharmaceuticals. Therefore, they chose to lend the Hughes a hand. As a result, they didn't reap any of the benefits due to the miserable defeat of the Hughes. More importantly, Eastcliff gained a lot of medical resources.

Matthew and Sasha. Afterward, they immediately began to discuss the terms for a new contract. In the end, they were successful in their negotiations and managed to renew their contracts with a 30% increase on

additional 30% was equivalent to 900 million. So, Cunningham Pharmaceuticals earned a pure profit of 900 million without doing anything. Sasha was still in shock despite holding the contracts in her hands. She knew that Cunningham Pharmaceuticals would be able to make a lot of money after Matthew gained the upper hand. However, she had not expected it

going back and forth, the renewed contracts had earned them a profit of 900 million. Combined with the contracts from Theodore previously, Cunningham Pharmaceuticals had already

no more than 100 million. In contrast, the company

After all, they, too, would receive generous bonuses if the company was raking

going to be making a lot of money, they were equally happy too. As for the matter of giving out

Cunningham Pharmaceuticals felt very festive-nobody could hide the joy on their faces. Furthermore, their subsidiary company Wellness Herbary received bonuses too. Naturally, where there was joy, there was sorrow too. Previously, Cunningham Pharmaceuticals had dozens of smaller shareholders but only several were left now, including Jefford. Back